FBXW7 suppresses HMGB1-mediated innate immune signaling to attenuate hepatic inflammation and insulin resistance in a mouse model of nonalcoholic fatty liver disease. The gene discussed is HMGB1; the disease is metabolic dysfunction-associated steatotic liver disease.